PIPELINE
For a better future SCM Lifescience will do its best
CoImmune Pipeline
Pipeline
pipeline
preclinical
Phase 1
clinical trial
Phase 2
clinical trial
Phase 3
clinical trial
Acute Lymphocytic Leukemia
Metastatic Kidney Cancer
Non-Hodgkins Lymphoma
Chronic Lymphocytic Leukemia
Colmmune is not our subsidiary company, but a company we invested in. The purpose of this section is just to introduce the pipeline of Colmmune.
Pipeline expansion plan
Diverse blood cancer / solid cancer portfolio expansion by adding indications
CAR-CIK
  • Chronic Lymphocytic
    Leukemia (CLL) 1
  • Non-Hodgkin’s
    Lymphoma (NHL)
Dendritic cells (DCs)
  • Liver Cancer
  • Lung Cancer